Alpha1 adrenoreceptors mediate the stimulatory effects of oestrogen on stress-related hypothalamic-pituitary-adrenal activity in the female rat.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000187:drug effects; D000818:Animals; D001127:Arginine Vasopressin / Q000187:drug effects / Q000378:metabolism*; D003346:Corticotropin-Releasing Hormone / Q000187:drug effects / Q000378:metabolism*; D004967:Estrogens / Q000502:physiology*; D030762:Estrous Cycle / Q000502:physiology*; D005260:Female; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000502:physiology; D008473:Median Eminence / Q000187:drug effects / Q000378:metabolism*; D010656:Phenylephrine / Q000494:pharmacology; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000502:physiology; D011224:Prazosin / Q000494:pharmacology; D011374:Progesterone / Q000502:physiology; D051381:Rats; D018340:Receptors, Adrenergic, alpha-1 / Q000187:drug effects / Q000502:physiology*; D013312:Stress, Physiological / Q000503:physiopathology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D004967:Estrogens; D018340:Receptors, Adrenergic, alpha-1; D001127:Arginine Vasopressin; D010656:Phenylephrine; D011374:Progesterone; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D011224:Prazosin